ContraFect Corp (CFRX)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 535.24K
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 0.00
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
0.29
Technicals
50-Day MA
0.186
200-Day MA
1.0271
52 Week High
N/A
52 Week Low
N/A
About CFRX
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious dis.
Employees
23
Headquarters
Yonkers, NY
CEO
Dr. Roger James Pomerantz F.A.C.P., FACP, M.D.
Latest News
ContraFect (CFRX) Stock Price Rose 37.6% on the Nasdaq Appeal - AskTraders.com
2023-01-31 • Google News
What's Going On With ContraFecta Stock Today - Yahoo Finance
2023-04-27 • Google News